The investigators evaluated the effectiveness of the application of analysing treadmill, muscle strengthening and balance training compared to a control intervention in patients with diabetic neuropathy.
Recent studies witnessed how physical exercise may interrupt the devastating decrease of muscle performance in DSP and further experiments are underway to find more exercises for the recovery of motor function impairment. In fact the rehabilitation treatment, that aims at reducing motor disability, preserving gait functions and preventing falling risks, is an interesting therapeutic approach. Literature recommends balance re-training exercises, muscle strengthening, selective stretching and retraining of motor activity. New technologies produced in the recent decades different devices used in strengthening exercises (electromechanical dynamometers), balance recovery (balance platforms) and gait (analyzing treadmills) have visual feedbacks through which the patients may independently monitor accuracy and intensity of their exercises, being therefore strongly motivated and resulting in a high training intensity. These technologies are often used in rehabilitation of different patients, but are rarely employed for DSP. The purpose of this case control study was to examine the effectiveness of the application of analysing treadmill, muscle strengthening and balance training compared to a control intervention in patients with diabetic neuropathy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
36
The length of stride of reference used during the exercise is personalized and depends on the height of patients. Each patient carries out the feedback for 20 minutes with the aim of generating the most symmetric and regular gait. Patients, with the dynamometer, work on strengthening of flexor and extensor muscles with ankle speeds at 90°/sec and 120°/sec. The strengthening technique was performed twice for 10 minutes each time with a 1 minute rest between sets. The session ends with a 20-minute feedback on dynamic balance platform by carrying out exercises in which they need to reach randomly appearing targets. Subjects begin with 12 minutes the first 4 sessions, progress to 16 minutes the next 2 sessions, then 18' (2 sessions), and finally 20', if able, during the last 4 sessions.
When needed, more than on e therapist are employed in the intervention for safety reasons.
Habilita, Ospedale di Sarnico
Sarnico, Bergamo, Italy
Change from Baseline of 6-minute walk test
All evaluation procedures are performed by the same examiner who was blinded to the aims of the study and to which group the participants are allocated. The 6-minute walk test (6MWT) is used to assess endurance. The 6MWT quantifies functional mobility based on the distance in meters traveled in six minutes. This outcome is a measure of endurance and is particularly significant to evaluate the possibility to perform continuative tasks, that are particularly important for the rehabilitation of diabetic patients and are relevant for an autonomous life. Subjects are instructed to walk at a comfortable speed and subjects neurological are able to use assistive devices.
Time frame: 1 day after the treatment
Change from Baseline of 10-metres walk test
All evaluation procedures are performed by the same examiner who was blinded to the aims of the study and to which group the participants are allocated. The 10-metres walking test is used to assess gait speed. The speed is quantified with the 10-metres walk test (TWT) over the ground. The gait speed measurement is performed over the middle 6 meters of the TWT and patients are asked to walk at their comfortable speed. Subjects are instructed to walk at a comfortable speed and subjects neurological are able to use assistive devices.
Time frame: 1 day after the treatment
Followup change from Baseline of 6-minute walk test
All evaluation procedures are performed by the same examiner who was blinded to the aims of the study and to which group the participants are allocated. The 6-minute walk test (6MWT) is used to assess endurance. The 6MWT quantifies functional mobility based on the distance in meters traveled in six minutes. This outcome is a measure of endurance and is particularly significant to evaluate the possibility to perform continuative tasks, that are particularly important for the rehabilitation of diabetic patients and are relevant for an autonomous life. Subjects are instructed to walk at a comfortable speed and subjects neurological are able to use assistive devices.
Time frame: 30 days after the treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Followup change from Baseline of 10-metres walk test
All evaluation procedures are performed by the same examiner who was blinded to the aims of the study and to which group the participants are allocated. The 10-metres walking test is used to assess gait speed. The speed is quantified with the 10-metres walk test (TWT) over the ground. The gait speed measurement is performed over the middle 6 meters of the TWT and patients are asked to walk at their comfortable speed. Subjects are instructed to walk at a comfortable speed and subjects neurological are able to use assistive devices.
Time frame: 30 days after the treatment
Change from Baseline of the Functional Independence Measure (FIM)
Time frame: 1 day after the treatment
Change from Baseline of the Tinetti scale
Time frame: 1 day after the treatment
Change from Baseline of the Resting Energy Expenditure (REE)
Time frame: 1 day after the treatment
Change from Baseline of the Respiratory Rate (RR)
Time frame: 1 day after the treatment
Change from Baseline of the Heart Rate (HR)
Time frame: 1 day after the treatment
Change from Baseline of the oxygen saturation (SpO2)
Time frame: 1 day after the treatment
Change from Baseline of the maximal oxygen consumption (VO2 max)
Time frame: 1 day after the treatment
Change from Baseline of the expired minute volume (Ve)
Time frame: 1 day after the treatment
Change from Baseline of the fraction of expired air that is oxygen (FeO2)
Time frame: 1 day after the treatment
Change from Baseline of the Systolic Blood Pressure (SBP)
Time frame: 1 day after the treatment
Change from Baseline of the Diastolic Blood Pressure (DBP)
Time frame: 1 day after the treatment
Change from Baseline of the Glycated Hemoglobin (HbA1c)
Time frame: 1 day after the treatment
Followup change from Baseline of the Functional Independence Measure (FIM)
Time frame: 30 days after the treatment
Followup change from Baseline of the Tinetti scale
Time frame: 30 days after the treatment
Followup change from Baseline of the Resting Energy Expenditure (REE)
Time frame: 30 days after the treatment
Followup change from Baseline of the Respiratory Rate (RR)
Time frame: 30 days after the treatment
Followup change from Baseline of the Heart Rate (HR)
Time frame: 30 days after the treatment
Followup change from Baseline of the oxygen saturation (SpO2)
Time frame: 30 days after the treatment
Followup change from Baseline of the maximal oxygen consumption (VO2 max)
Time frame: 30 days after the treatment
Followup change from Baseline of the expired minute volume (Ve)
Time frame: 30 days after the treatment
Followup change from Baseline of the fraction of expired air that is oxygen (FeO2)
Time frame: 30 days after the treatment
Followup change from Baseline of the Systolic Blood Pressure (SBP)
Time frame: 30 days after the treatment
Followup change from Baseline of the Diastolic Blood Pressure (DBP)
Time frame: 30 days after the treatment
Followup change from Baseline of the Glycated Hemoglobin (HbA1c)
Time frame: 30 days after the treatment